INYDX | RGEBX | INYDX / RGEBX | |
Total Expense Ratio | 0.83 | 1.09 | 76% |
Annual Report Gross Expense Ratio | 0.83 | 1.09 | 76% |
Fund Existence | 17 years | 11 years | - |
Gain YTD | 14.828 | 13.942 | 106% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 5000000 | 250 | 2,000,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.24B | 329B | 1% |
Annual Yield % from dividends | 0.20 | 0.00 | - |
Returns for 1 year | 16.83 | 13.85 | 122% |
Returns for 3 years | 39.08 | 40.38 | 97% |
Returns for 5 years | 6.61 | 40.64 | 16% |
Returns for 10 years | 22.36 | 79.50 | 28% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
DSPIX | 56.08 | N/A | N/A |
BNY Mellon Instl S&P 500 Stk Idx I | |||
SHSKX | 63.37 | N/A | N/A |
BlackRock Health Sciences Opps K | |||
HMCLX | 15.20 | N/A | N/A |
Harbor Mid Cap Institutional | |||
OWLLX | 11.29 | N/A | N/A |
Channing Intrinsic Value Sm-Cp Instl | |||
MCSSX | 39.37 | -0.09 | -0.23% |
NYLI WMC Enduring Capital Investor Class |